• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis.比较肝切除术与肝移植术治疗早期肝细胞癌患者的疗效:荟萃分析。
HPB (Oxford). 2012 Sep;14(9):635-45. doi: 10.1111/j.1477-2574.2012.00500.x. Epub 2012 Jun 19.
2
Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.肝细胞癌意向性治疗中肝移植与肝切除术的比较:进行理想荟萃分析的尝试。
Liver Transpl. 2017 Jun;23(6):836-844. doi: 10.1002/lt.24758.
3
Liver transplantation vs liver resection in patients with HBV-related hepatocellular carcinoma beyond Milan criterion: A meta-analysis.肝移植与米兰标准以外的 HBV 相关肝细胞癌患者的肝切除术:一项荟萃分析。
Clin Transplant. 2018 Mar;32(3):e13193. doi: 10.1111/ctr.13193. Epub 2018 Jan 30.
4
Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter.直径达8厘米的孤立性肝细胞癌患者接受活体供肝原位肝移植后的长期良好生存情况。
HPB (Oxford). 2014 Aug;16(8):749-57. doi: 10.1111/hpb.12212. Epub 2014 Jan 28.
5
Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria.对于符合米兰标准的多发性结节Child-Pugh A级肝细胞癌患者,进行活体供肝肝移植或肝切除术。
Transpl Int. 2014 Jun;27(6):562-9. doi: 10.1111/tri.12297. Epub 2014 Apr 2.
6
Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.米兰标准以外的肝细胞癌患者的肝切除与肝移植
Ann Surg. 2016 Oct;264(4):650-8. doi: 10.1097/SLA.0000000000001866.
7
Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?肝切除术作为肝硬化合并肝细胞癌患者肝移植的过渡手段:一种合理的策略?
Ann Surg. 2003 Oct;238(4):508-18; discussion 518-9. doi: 10.1097/01.sla.0000090449.87109.44.
8
Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?复发性肝细胞癌的治疗策略:挽救性移植、再次切除还是射频消融?
Liver Transpl. 2013 Apr;19(4):411-9. doi: 10.1002/lt.23605. Epub 2013 Mar 17.
9
Hepatocellular carcinoma: surgical perspectives beyond the barcelona clinic liver cancer recommendations.肝细胞癌:超越巴塞罗那临床肝癌推荐方案的外科治疗观点
World J Gastroenterol. 2014 Jun 28;20(24):7525-33. doi: 10.3748/wjg.v20.i24.7525.
10
AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.甲胎蛋白水平和组织学分化可预测肝癌患者肝移植的生存率。
Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):256-61. doi: 10.1016/s1499-3872(12)60157-x.

引用本文的文献

1
MR elastography-based prediction of development of hepatocellular carcinoma in patients with chronic hepatitis B with sustained virological response.基于磁共振弹性成像对慢性乙型肝炎病毒持续学应答患者肝细胞癌发生发展的预测
Eur Radiol. 2025 Jun 12. doi: 10.1007/s00330-025-11726-7.
2
Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients.肝癌筛查在当代高危患者队列中的应用。
JAMA Netw Open. 2024 Apr 1;7(4):e248755. doi: 10.1001/jamanetworkopen.2024.8755.
3
Liver transplantation vs liver resection in HCC: promoting extensive collaborative research through a survival meta-analysis of meta-analyses.肝细胞癌肝移植与肝切除术的比较:通过荟萃分析的生存荟萃分析促进广泛的合作研究。
Front Oncol. 2024 Mar 18;14:1366607. doi: 10.3389/fonc.2024.1366607. eCollection 2024.
4
Surgical management of hepatocellular carcinoma-Western versus Eastern attitude.肝细胞癌的外科治疗——西方与东方的态度
Transl Cancer Res. 2019 Apr;8(Suppl 3):S245-S260. doi: 10.21037/tcr.2018.12.28.
5
The Treatment Effect of Liver Transplantation versus Liver Resection for HCC: A Review and Future Perspectives.肝癌肝移植与肝切除的治疗效果:综述与未来展望
Cancers (Basel). 2021 Jul 24;13(15):3730. doi: 10.3390/cancers13153730.
6
A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis.一种用于肝硬化患者肝细胞癌早期检测和风险评估的新型生物标志物组合。
Cancer Prev Res (Phila). 2021 Jun;14(6):667-674. doi: 10.1158/1940-6207.CAPR-20-0600. Epub 2021 Mar 8.
7
7-T MRI of explanted liver and ex-vivo pancreatic specimens: prospective study protocol of radiological-pathological correlation feasibility (the EXLIPSE project).移植肝脏和离体胰腺标本的7-T磁共振成像:放射学与病理学相关性可行性的前瞻性研究方案(EXLIPSE项目)
Eur Radiol Exp. 2020 Oct 15;4(1):58. doi: 10.1186/s41747-020-00185-y.
8
Panx1 promotes invasion-metastasis cascade in hepatocellular carcinoma.Panx1促进肝细胞癌的侵袭转移级联反应。
J Cancer. 2019 Sep 7;10(23):5681-5688. doi: 10.7150/jca.32986. eCollection 2019.
9
Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis.肝癌筛查可提高肝硬化患者的生存率。
Clin Gastroenterol Hepatol. 2019 Apr;17(5):976-987.e4. doi: 10.1016/j.cgh.2018.10.031. Epub 2018 Oct 26.
10
Liver Transplantation and Liver Resection for Cirrhotic Patients with Hepatocellular Carcinoma: Comparison of Long-Term Survivals.肝硬化肝细胞癌患者行肝移植与肝切除术的长期生存比较。
J Gastrointest Surg. 2018 May;22(5):840-848. doi: 10.1007/s11605-018-3690-4. Epub 2018 Jan 23.

本文引用的文献

1
Is the treatment of hepatocellular carcinoma on the waiting list necessary?等待名单上的肝细胞癌患者是否需要治疗?
Liver Transpl. 2011 Oct;17 Suppl 2:S98-108. doi: 10.1002/lt.22391.
2
Presentation and outcomes of hepatocellular carcinoma patients at a western centre.西部中心肝细胞癌患者的表现和结局。
HPB (Oxford). 2011 Oct;13(10):712-22. doi: 10.1111/j.1477-2574.2011.00362.x. Epub 2011 Aug 11.
3
Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma?手术切除在治疗肝细胞癌方面优于移植吗?
Ann Surg. 2011 Sep;254(3):527-37; discussion 537-8. doi: 10.1097/SLA.0b013e31822ca66f.
4
Influence of margins on overall survival after hepatic resection for colorectal metastasis: a meta-analysis.肝切除治疗结直肠转移术后切缘对总生存的影响:荟萃分析。
Ann Surg. 2011 Aug;254(2):234-42. doi: 10.1097/SLA.0b013e318223c609.
5
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.癌症统计数据,2011 年:消除社会经济和种族差异对癌症过早死亡的影响。
CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36. doi: 10.3322/caac.20121. Epub 2011 Jun 17.
6
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
7
Hepatocellular carcinoma: current management and perspectives for the future.肝细胞癌:当前的治疗管理与未来展望。
Ann Surg. 2011 Mar;253(3):453-69. doi: 10.1097/SLA.0b013e31820d944f.
8
Understanding surgical decision making in early hepatocellular carcinoma.理解早期肝细胞癌的手术决策。
J Clin Oncol. 2011 Feb 20;29(6):619-25. doi: 10.1200/JCO.2010.30.8650. Epub 2011 Jan 4.
9
Comparative analysis of outcome in patients with hepatocellular carcinoma exceeding the milan criteria treated with liver transplantation versus partial hepatectomy.米兰标准外肝癌患者行肝移植与部分肝切除术后结局的对比分析。
Am J Clin Oncol. 2011 Oct;34(5):466-71. doi: 10.1097/COC.0b013e3181ec63dd.
10
Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation.小肝细胞癌的治疗管理:移植、切除和消融的综述。
Ann Surg Oncol. 2010 May;17(5):1226-33. doi: 10.1245/s10434-010-0978-3. Epub 2010 Apr 20.

比较肝切除术与肝移植术治疗早期肝细胞癌患者的疗效:荟萃分析。

Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis.

机构信息

Department of Surgery, Division of Surgical Oncology, Eppley Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA.

出版信息

HPB (Oxford). 2012 Sep;14(9):635-45. doi: 10.1111/j.1477-2574.2012.00500.x. Epub 2012 Jun 19.

DOI:10.1111/j.1477-2574.2012.00500.x
PMID:22882201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3461390/
Abstract

OBJECTIVES

Surgical decision making for patients with early hepatocellular carcinoma (HCC) and well-compensated cirrhosis remains controversial. The aim of the current study was to conduct a meta-analysis of published reports to compare survival outcomes after transplantation and resection, respectively, in patients with early HCC [i.e. HCC falling within the Milan Criteria (a solitary lesion measuring ≤5 cm or fewer than three lesions with a largest diameter of ≤3 cm, and absence of macroscopic vascular invasion or extrahepatic disease)] and well-compensated cirrhosis.

METHODS

A total of 990 abstracts were identified through a PubMed-based search. Ten articles comparing transplantation and resection in patients with early HCC were included in the meta-analysis. Meta-analysis was performed using stata 9.2 statistical software.

RESULTS

Outcomes were analysed for a total of 1763 patients with early HCC. The 5-year overall survival (OS) for all patients was 58% (transplantation: 63%; resection: 53%). Meta-analysis of all 10 studies revealed a survival advantage for transplantation [odds ratio (OR) 0.581, 95% confidence interval (CI) 0.359-0.939; P = 0.027]. Analysis of only those reports that utilized an 'intention-to-treat' strategy failed to demonstrate a survival advantage for either treatment approach (OR 0.600, 95% CI 0.291-1.237; P = 0.166).

CONCLUSIONS

The current study demonstrates a favourable outcome in patients with early HCC treated by either transplantation or resection. Although transplantation was noted to have a survival advantage in some settings, resection continues to be a viable treatment approach.

摘要

目的

对于早期肝细胞癌(HCC)和代偿良好的肝硬化患者的手术决策仍存在争议。本研究的目的是对已发表的报告进行荟萃分析,以比较分别接受移植和切除术治疗的早期 HCC [即符合米兰标准(单个病变最大直径≤5cm 或不超过 3 个病变且最大直径均≤3cm,无肉眼血管侵犯或肝外疾病)]和代偿良好的肝硬化患者的生存结果。

方法

通过基于 PubMed 的搜索共确定了 990 个摘要。共有 10 篇比较早期 HCC 患者移植和切除术的文章纳入荟萃分析。使用 stata 9.2 统计软件进行荟萃分析。

结果

对总共 1763 例早期 HCC 患者进行了结果分析。所有患者的 5 年总生存率(OS)为 58%(移植:63%;切除:53%)。对所有 10 项研究的荟萃分析显示,移植具有生存优势[比值比(OR)0.581,95%置信区间(CI)0.359-0.939;P=0.027]。仅分析那些采用“意向治疗”策略的报告未能表明两种治疗方法都具有生存优势(OR 0.600,95%CI 0.291-1.237;P=0.166)。

结论

本研究表明,早期 HCC 患者接受移植或切除术治疗都有较好的结果。虽然在某些情况下移植具有生存优势,但切除术仍然是一种可行的治疗方法。